Stonebridge Capital Advisors LLC Abbott Laboratories Transaction History

Stonebridge Capital Advisors LLC

$1.19 Billion
Q3 2024

A detailed history of Stonebridge Capital Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stonebridge Capital Advisors LLC holds 21,104 shares of ABT stock, worth $2.72 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

21,104

Previous 21,104 -0.0%

Holding current value

$2.72 Million

Previous $2.19 Million 9.76%

% of portfolio

0.2%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $100,427 - $112,102	997 Added 4.96%	21,104 $2.19 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $26,722 - $29,514	-244 Reduced 1.2%	20,107 $2.29 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $3,343 - $4,011	-35 Reduced 0.17%	20,351 $1.97 Million
Q2 2023 Aug 23, 2023	SELL	$100.78 - $112.29 $3,527 - $3,930	-35 Reduced 0.17%	20,386 $2.22 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $5,230 - $6,156	54 Added 0.27%	20,421 $2.07 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $20,532 - $24,088	216 Added 1.07%	20,367 $2.24 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $15,384 - $17,812	159 Added 0.8%	20,151 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $3,776 - $4,564	-37 Reduced 0.18%	19,992 $2.17 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $11,402 - $13,904	100 Added 0.5%	20,029 $2.37 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $24,838 - $30,413	215 Added 1.09%	19,929 $2.81 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.59 Million - $1.76 Million	13,656 Added 225.42%	19,714 $2.33 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $12,625 - $14,874	-116 Reduced 1.88%	6,058 $726,000
Q4 2020 Mar 05, 2021	BUY	$105.0 - $114.42 $294,105 - $320,490	2,801 Added 83.04%	6,174 $676,000
Q3 2020 Nov 18, 2020	SELL	$91.64 - $111.29 $9,072 - $11,017	-99 Reduced 2.85%	3,373 $367,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $67,764 - $86,730	885 Added 34.21%	3,472 $317,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $46,298 - $67,700	-737 Reduced 22.17%	2,587 $204,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $73,956 - $82,330	-942 Reduced 22.08%	3,324 $289,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $59,252 - $64,247	-724 Reduced 14.51%	4,266 $357,000
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Reduced 1.96%	4,990 $420,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $17,415 - $21,055	-263 Reduced 4.91%	5,090 $407,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $36,779 - $41,665	-561 Reduced 9.49%	5,353 $387,000
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $1,702 - $2,054	-28 Reduced 0.47%	5,914 $434,000
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $7,689 - $8,582	160 Added 2.77%	5,942 $317,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,782	5,782 $281,000

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.

Account

Stonebridge Capital Advisors LLC Abbott Laboratories Transaction History